Skip to main content

In re Suboxone (Buprenorphine Hydrochloride & Nalaxone) Antitrust Litig. (3d Cir. July 28, 2020)

Available in the following formats:

In-re-Suboxone-Antitrust-Litig.pdf

Issued:

Date

2020

Related NCLC Treatise:

Consumer Class Actions

Learn More